# Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

> **NCT06097468** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 40 (estimated)

## Conditions studied

- Oral Cavity Squamous Cell Carcinoma

## Interventions

- **DRUG:** NisinZ® P
- **PROCEDURE:** Surgery (non-interventional, standard of care)

## Key facts

- **NCT ID:** NCT06097468
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-02
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-10-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06097468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06097468, "Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT06097468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*